Remifentanil is a potent opioid widely used during the administration of general anesthesia. There is a lot of evidence that suggest that the used of remifentanil is associated with the development of hyperalgesia (a reduction of nociceptive thresholds). However, the mechanism of this hyperalgesia is not fully understood. Recently, it was demonstrated that the disruption of the Cl- homeostasis could be involved. Interestingly, this was prevented in a murine model with the administration of Acetazolamide, a carbonic anhydrase inhibitor. In our clinical trial we will try to determine if the preoperative administration of acetazolamide could prevent the hyperalgesia induced by remifentanil in patients scheduled for thyroidectomy with general anesthesia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
50
Faculty of Medicine, University of Chile
Santiago, Santiago Metropolitan, Chile
Change in the mechanical pain threshold in an area distant to the site of the injury
The threshold will be determine using von Frey monofilaments before the surgery and will be compared 12-18 hours after the end of the surgery
Time frame: 12-18 hours after the end of the surgery
Change in the mechanical pain threshold in an area distant to the site of the injury
Time frame: 2 hours after the end of the surgery
Postoperative pain
A visual analogue scale (VAS; 0, no pain; 100, worst poss- ible pain) will be used to assess pain
Time frame: The first postoperative day
Morphine consumption
Morphine consumption with a patient controlled analgesia (PCA) in mg
Time frame: The first postoperative day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.